Information Provided By:
Fly News Breaks for February 12, 2019
MDSO
Feb 12, 2019 | 18:44 EDT
Piper Jaffray analyst Sean Wieland kept his Overweight rating and $83 price target on Medidata, saying the company's Q4 earnings beat demonstrates its leadership in clinical development data platforms . The analyst cites the company's near-zero attrition and solid mid-teen revenue growth in the quarter, adding that its cross-sell initiative is also successful given its 1.2K customers with a renewal rate near 100%.
News For MDSO From the Last 2 Days
There are no results for your query MDSO